Elotuzumab
(UPDATE) Daratumumab (MM)
Carfilzomib
(UPDATE) Ixazomib
The Leukemia and Lymphoma Society
ASH: COVID-19 Resources for Managing Blood Cancers
NCCN-Funded Clinical Trials: Find a Clinical Trial
International Myeloma Foundation (IMF)